Palvella Therapeutics (PVLA) Long-Term Investments (2017 - 2022)

Palvella Therapeutics (PVLA) has 5 years of Long-Term Investments data on file, last reported at $4.5 million in Q2 2022.

• On a quarterly basis, Long-Term Investments changed N/A year-over-year to $4.5 million in Q2 2022; TTM through Jun 2022 was $4.5 million, a N/A change from a year earlier, with the FY2019 full-year figure at $28.6 million, up 397.46% from the prior year.
• Long-Term Investments for Q2 2022 stood at $4.5 million, down from $9.0 million in the prior quarter.
• Over the last five years, Long-Term Investments for PVLA reached as high as $38.9 million in Q1 2019 and fell as low as $700000.0 in Q2 2018.
• Historically, Long-Term Investments has averaged $10.4 million across 4 years, with a median of $5.7 million in 2018.
• Across the five-year window, Long-Term Investments jumped 1406.93% in 2019 and plunged 85.32% in 2020, its largest moves.
• Year by year, Long-Term Investments stood at $5.8 million in 2018, then surged by 397.46% to $28.6 million in 2019, then plunged by 68.58% to $9.0 million in 2020, then sank by 49.54% to $4.5 million in 2022.
• Per Business Quant data, the three most recent Long-Term Investments figures were $4.5 million in Q2 2022, $9.0 million in Q3 2020, and $1.6 million in Q2 2020.